Investors may be expecting future growth or cost cutting due...
Investors may be expecting future growth or cost cutting due to the company's lack of profits and revenue growth. The company's performance over the last five years has resulted in a total loss of 0.9% per year for shareholders.
Even After Rising 23% This Past Week, Dali Pharmaceuticalco.Ltd (SHSE:603963) Shareholders Are Still Down 30% Over the Past Year
Disclaimer: The above information does not represent the views of Moomoo Technologies Inc. (MTI) or constitute investment advice related to MTI and its affiliates.
Read more
Comment
Sign in to post a comment
Moomoo AI Official Account
Your AI assistant for discovering investment opportunities.
4321Followers
0Following
9490Visitors
Follow